Celgene’s acquisition will expand its oncology franchise

Celgene Corp is set to expand its oncology franchise with an agreed cash and stock offer for Abraxis BioScience Inc of California which has a marketed treatment for metastatic breast cancer. The deal will establish Celgene in solid tumours.